Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug 12;4(3):606-19.
doi: 10.3390/pathogens4030606.

Interleukin 17-Mediated Host Defense against Candida albicans

Florian Sparber  1 , Salomé LeibundGut-Landmann  2
Affiliations
Review

Interleukin 17-Mediated Host Defense against Candida albicans

Florian Sparber et al. Pathogens. .

Abstract

Candida albicans is part of the normal microbiota in most healthy individuals. However, it can cause opportunistic infections if host defenses are breached, with symptoms ranging from superficial lesions to severe systemic disease. The study of rare congenital defects in patients with chronic mucocutaneous candidiasis led to the identification of interleukin-17 (IL-17) as a key factor in host defense against mucosal fungal infection. Experimental infections in mice confirmed the critical role of IL-17 in mucocutaneous immunity against C. albicans. Research on mouse models has also contributed importantly to our current understanding of the regulation of IL-17 production by different cellular sources and its effector functions in distinct tissues. In this review, we highlight recent findings on IL-17-mediated immunity against C. albicans in mouse and man.

Keywords: chronic mucocutaneous candidiasis; interleukin 17; mouse models.

PubMed Disclaimer

References

    1. Underhill D.M., Iliev I.D. The mycobiota: interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 2014;14:405–416. doi: 10.1038/nri3684. - DOI - PMC - PubMed
    1. Moran G., Coleman D., Sullivan D. Candida and Candidiasis. 2nd ed. ASM Press; Washington, DC, USA: 2012. An introduction to the medically important Candida species; pp. 11–25.
    1. Vazquez J.A., Sobel J.D. Mucosal candidiasis. Infect. Dis. Clin. North Am. 2002;16:793–820. doi: 10.1016/S0891-5520(02)00042-9. - DOI - PubMed
    1. Zaoutis T.E., Argon J., Chu J., Berlin J.A., Walsh T.J., Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin. Infect. Dis. 2005;41:1232–1239. doi: 10.1086/496922. - DOI - PubMed
    1. Horn D.L., Neofytos D., Anaissie E.J., Fishman J.A., Steinbach W.J., Olyaei A.J., Marr K.A., Pfaller M.A., Chang C.-H., Webster K.M. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 2009;48:1695–1703. doi: 10.1086/599039. - DOI - PubMed

LinkOut - more resources